Full text is available at the source.
Abstract
CAIL-based lipid nanoparticles achieve robust mRNA translation in splenic NK cells, inducing transfection in 21% of these cells.
- A library of 161 carbonate-bearing ionizable lipids was designed to enhance mRNA delivery to NK cells.
- These lipid nanoparticles (LNPs) primarily target the spleen rather than the liver, unlike traditional LNPs.
- Removing cholesterol from CAIL LNPs significantly improves spleen-targeting specificity and efficacy.
- Optimized CAIL LNPs may effectively address the challenges of mRNA delivery to NK cells.
- The findings suggest potential for developing NK cell-based mRNA therapies.
Simplified